Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 1/20 | 0.57 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.57 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL755636 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL9751433 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL44028 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL2901529 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL1070643 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL24398977 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL11576564 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL21924992 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL20774497 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 | |
| SCHEMBL4448701 | 1.00 | LPAR1 (0.57) | LPAR1LPAR2LPAR3FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12497556-B2 | Emulsions including polymers, treatment fluids including emulsions, and methods for treating subterranean formations | STERLING SPECIALTY CHEMICALS HOLDING UK LIMITED (GB) | 2025-12-16 | — | — | US | disclosed |
| US-12296014-B2 | External preparation comprising non-lamellar liquid crystal-forming lipid | FARNEX INCORPORATED (JP) | 2025-05-13 | — | — | US | disclosed |
| WO-2025027033-A1 | SILICONE-FREE CARE COMPOSITION FOR KERATINOUS MATERIALS | L'OREAL (FR) | 2025-02-06 | — | — | WO | disclosed |
| US-12129424-B2 | Friction reducers for high TDS brines | STERLING SPECIALTY CHEMICALS HOLDING UK LIMITED (GB) | 2024-10-29 | — | — | US | disclosed |
| US-20240084190-A1 | EMULSIONS INCLUDING POLYMERS, TREATMENT FLUIDS INCLUDING EMULSIONS, AND METHODS FOR TREATING SUBTERRANEAN FORMATIONS | STERLING SPECIALTY CHEMICALS HOLDING UK LIMITED (GB) | 2024-03-14 | — | — | US | disclosed |
| US-11859128-B2 | Emulsions including polymers, treatment fluids including emulsions, and methods for treating subterranean formations | KEMIRA OYJ (FI) | 2024-01-02 | — | — | US | disclosed |
| EP-3303286-B1 | COMPOUNDS THAT BIND TO RELA OF NF-KB FOR USE IN TREATING CANCER | CEDARS SINAI MEDICAL CENTER (US) | 2023-10-04 | — | — | EP | disclosed |
| US-20230019003-A1 | FRICTION REDUCERS FOR HIGH TDS BRINES | KEMIRA OYJ (FI) | 2023-01-19 | — | — | US | disclosed |
| EP-3980507-A1 | FRICTION REDUCERS FOR HIGH TDS BRINES | Kemira OYJ (FI) | 2022-04-13 | — | — | EP | disclosed |
| US-20210085649-A1 | METHODS AND USE OF COMPOUNDS THAT BIND TO RELA OF NF-KB | CEDARS-SINAI MEDICAL CENTER (US) | 2021-03-25 | — | — | US | disclosed |
| EP-1256606-B1 | Pigment containing ink and production method thereof | CANON KK (JP) | 2006-03-08 | — | — | EP | disclosed |
| US-6916861-B2 | Pigment containing ink and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2005-07-12 | — | — | US | disclosed |
| EP-1262229-B1 | Coloring composition containing a pigment coated by a polyhydroxyalkanoate | CANON KK (JP) | 2005-05-04 | — | — | EP | disclosed |
| WO-2004096188-A1 | POLYHYDROXYALKANOATE-CONTAINING MAGNETIC STRUCTURE, AND MANUFACTURING METHOD AND USE THEREOF | CANON KABUSHIKI KAISHA (JP) | 2004-11-11 | — | — | WO | disclosed |
| EP-1277464-B1 | Liposome coated with polyhydroxyalkanoate and production method thereof | CANON KK (JP) | 2004-10-06 | — | — | EP | disclosed |
| US-20030203458-A1 | Coloring composition for color filters containing microencapsulated pigment composed of polyhydroxyalkanoate | CANON KABUSHIKI KAISHA (JP) | 2003-10-30 | — | — | US | disclosed |
| US-20030203987-A1 | Pigment containing ink and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-10-30 | — | — | US | disclosed |
| US-20030113368-A1 | Liposome coated with polyhydroxyalkanoate and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1262229-A1 | Coloring composition containing a pigment coated by a polyhydroxyalkanoate | CANON KABUSHIKI KAISHA (JP) | 2002-12-04 | — | — | EP | disclosed |
| EP-1256606-A2 | Pigment containing ink and production method thereof | CANON KABUSHIKI KAISHA (JP) | 2002-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12296014-B2 | External preparation comprising non-lamellar liquid crystal-forming lipid | LIPA, LIPC, CETP | LPAR1 123/4885LPAR2 146/4885LPAR3 344/4885 |
| US-20030113368-A1 | Liposome coated with polyhydroxyalkanoate and production method thereof | LIPA, ABHD16A, LIPE | LPAR1 59/4885LPAR2 44/4885LPAR3 119/4885 |
| US-20210085649-A1 | METHODS AND USE OF COMPOUNDS THAT BIND TO RELA OF NF-KB | NFKBIA, RELA, NFKB1 | LPAR1 3652/4885LPAR2 3904/4885LPAR3 3490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.